Ignite Creation Date:
2024-05-06 @ 6:44 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05765084
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-02-13
Brief Title:
Integration of the PD-L1 Inhibitor Atezolizumab and WT1DC Vaccination Into PlatinumPemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
Sponsor:
Organization:
University Hospital Antwerp